- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Organ Transplantation Techniques and Outcomes
- Liver Disease Diagnosis and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Organ Donation and Transplantation
- Pancreatic and Hepatic Oncology Research
- Hepatitis C virus research
- Gallbladder and Bile Duct Disorders
- Renal Transplantation Outcomes and Treatments
- Pediatric Hepatobiliary Diseases and Treatments
- Transplantation: Methods and Outcomes
- HIV/AIDS drug development and treatment
- Renal and Vascular Pathologies
- Hepatitis B Virus Studies
- Pneumocystis jirovecii pneumonia detection and treatment
- Liver physiology and pathology
- Gastric Cancer Management and Outcomes
- Cancer, Lipids, and Metabolism
- Renal cell carcinoma treatment
- Viral-associated cancers and disorders
- Abdominal Trauma and Injuries
- Colorectal Cancer Treatments and Studies
- Genetic and Kidney Cyst Diseases
- Multiple and Secondary Primary Cancers
University of Modena and Reggio Emilia
2009-2025
Azienda Ospedaliero-Universitaria di Modena
2006-2024
GTx (United States)
2023
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
2012-2021
Universidade Federal do Maranhão
2021
Novem (Netherlands)
2021
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2017-2020
Jackson and Tull (United States)
2020
University of Milano-Bicocca
2016-2020
University of Florence
2020
Objective: The aim of this study was to estimate probabilities achieving the statistical cure from hepatocellular carcinoma (HCC) with hepatic resection (HR) and liver transplantation (LT). Background: Statistical occurs when mortality a specific population returns values that general population. Resection are considered potentially curative therapies for HCC, but their effect on residual entire life-expectancy has never been investigated. Methods: Data 3286 HCC patients treated LT (n =...
Long-term oncologic outcomes of robotic surgery remain a hotly debated topic in surgical oncology, but sparse data have been published thus far.
The role of donation after cardiac death (DCD) in expanding the donor pool is mainly limited by incidence primary nonfunction (PNF) and ischemia-related complications. Even greater concern exists toward uncontrolled DCD, which represents largest potential DCD donors. We recently started first Italian series liver transplantation, using normothermic regional perfusion (NRP) 6 donors 1 controlled case to deal with legally required no-touch period 20 minutes. examined our 7 cases for PNF, early...
Donation after circulatory death (DCD) in Italy, given its 20-min stand-off period, provides a unique bench test for normothermic regional perfusion (NRP) and dual hypothermic oxygenated machine (D-HOPE).We coordinated multicenter retrospective Italian cohort study with 44 controlled DCD donors, who underwent NRP, to present transplant characteristics results. To rank our results according the high donor risk, we matched compared subgroup of 37 livers, preserved NRP D-HOPE, static-preserved...
Donation after circulatory death (DCD) in Italy constitutes a relatively unique population because of the requirement no-touch period 20 minutes. The first aim this study was to compare liver transplantations from donors who were maintained on normothermic regional perfusion and suffered extended warm ischemia (DCD group, n = 20) with those extracorporeal membrane oxygenation (ECMO) succumbed brain (ECMO 17) standard (donation [DBD] 52). Second, we conducted an explorative analysis DCD group...
Major concerns about donor morbidity and mortality still limit the use of living liver transplantation (LDLT) to overcome organ shortage. The present study assessed safety in LDLT Italy reporting postoperative outcomes 246 donation procedures performed by 7 transplant centers. Outcomes were evaluated over 2 time periods using validated Clavien 5‐tier grading system, several clinical variables analyzed determine risk factors for morbidity. Different grafts obtained from (220 right lobe, 10...
To report the first European series of full robotic whole liver transplantation (RLT) with technical details and future perspectives.
Some experimental trials have demonstrated that rapamycin (RAPA) is able to inhibit HIV-1 progression in three different ways: (1) reducing CCR5-gene transcription, (2) blocking interleukin-2 intracellular secondary messenger (mammalian target of rapamycin), and (3) up-regulating the beta-chemokine macrophage inflammatory protein (MIP; MIP-1alpha MIP-1beta). We present preliminary results a prospective nonrandomized trial concerning first HIV patient series receiving RAPA monotherapy after...
The aim of this study was to collect data from patients who underwent liver transplantation (LT) for adenomatosis; analyze the symptoms, characteristics disease, and recipient outcomes; better define role LT in rare indication. This retrospective multicenter study, based on European Liver Transplant Registry, encompassed adenomatosis between January 1, 1986, July 15, 2013, Europe. Patients with glycogen storage disease (GSD) type IA were not excluded. included 49 patients. Sixteen had GSD, 7...
Early-stage hepatocellular carcinoma could benefit from upfront liver resection (LR) or transplantation (LT), but the optimal strategy in terms of tumor-related outcomes is still debated. We compared oncological LR and LT for carcinoma, stratifying study population into a low-, intermediate-, high-risk class according to risk death at 5-y predicted by previously developed prognostic model. The impact tumor pathology on low- intermediate-risk patients undergoing was investigated as secondary...
ABSTRACT Introduction Liver transplantation (LT) is the sole curative option for liver failure and other primary conditions. However, limited number of suitable donors compared with growing patients requiring LT remains a leading cause mortality among those on waiting list. This has resulted in expansion criteria donor eligibility. The sequential combination ex situ reperfusion, dHOPE, NMP helps reduce occurrence ischemia–reperfusion injury assess organ viability prior to transplantation....